Clorox Company (The) (CLX) Earns Hold Rating from Deutsche Bank AG

Clorox Company (The) (NYSE:CLX)‘s stock had its “hold” rating reissued by analysts at Deutsche Bank AG in a research report issued on Saturday, July 22nd. They presently have a $137.00 target price on the stock, up from their prior target price of $126.00. Deutsche Bank AG’s target price indicates a potential upside of 2.00% from the company’s previous close.

Other equities research analysts have also recently issued research reports about the company. UBS AG reissued a “sell” rating and set a $121.00 target price (up previously from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. Zacks Investment Research raised Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 target price for the company in a research note on Tuesday, July 4th. Royal Bank Of Canada reissued a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a research note on Friday, June 30th. BidaskClub cut Clorox Company (The) from a “hold” rating to a “sell” rating in a research note on Wednesday, July 5th. Finally, BMO Capital Markets reissued a “buy” rating and set a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus target price of $129.05.

Clorox Company (NYSE:CLX) opened at 134.31 on Friday. The firm has a 50-day moving average price of $133.58 and a 200 day moving average price of $133.56. The company has a market cap of $17.34 billion, a P/E ratio of 25.18 and a beta of 0.40. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter last year, the business posted $1.30 earnings per share. The firm’s revenue was up 2.9% compared to the same quarter last year. Equities research analysts predict that Clorox Company will post $5.67 EPS for the current year.

TRADEMARK VIOLATION WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://www.com-unik.info/2017/08/12/deutsche-bank-ag-reaffirms-hold-rating-for-clorox-company-the-clx-updated-updated.html.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Jacobi Capital Management LLC raised its position in Clorox Company (The) by 0.3% in the first quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock worth $172,000 after buying an additional 4 shares during the period. Bridgeworth LLC raised its position in Clorox Company (The) by 0.3% in the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock worth $252,000 after buying an additional 5 shares during the period. Valley National Advisers Inc. raised its position in Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares during the period. Blue Chip Partners Inc. raised its position in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the period. Finally, Bernzott Capital Advisors raised its position in Clorox Company (The) by 0.4% in the second quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock worth $214,000 after buying an additional 7 shares during the period. Hedge funds and other institutional investors own 70.29% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

What are top analysts saying about Clorox Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Clorox Company (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit